We are live on ! Find out more
VIVS

VivoSim Labs

50 hedge funds and large institutions have $21.4M invested in VivoSim Labs in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

11% more funds holding

Funds holding: 4550 (+5)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.62% less ownership

Funds ownership: 2.81%2.2% (-0.62%)

8% less capital invested

Capital invested by funds: $23.1M → $21.4M (-$1.74M)

Holders
50
Holders Change
+5
Holders Change %
+11.11%
% of All Funds
0.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
9
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change

VIVS Hedge Fund Activity: Q2 2021 in Review

50 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2021, worth a combined $21.4M — down 7.5% from $23.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VIVS positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $845K. The largest seller was ARK Investment Management, cutting an estimated $1.49M.

  • 50 institutional investors held VivoSim Labs (VIVS) as of Q2 2021, up from 45 in Q1 2021.
  • Funds reported $21.4M of VivoSim Labs stock for Q2 2021, down 7.5% quarter-over-quarter.
  • 11 funds opened new VivoSim Labs positions in Q2 2021 and 6 closed out, a net change of +5 holders.
  • The largest VivoSim Labs buyer in Q2 2021 was Vanguard Group, an estimated $845K added.
  • The largest VivoSim Labs seller in Q2 2021 was ARK Investment Management, an estimated $1.49M sold.

Based on aggregated 13F filings for Q2 2021.